Tatva Chintan Pharma Chem Limited (TATVA) Stock - Complete Technical Analysis - Nov 26, 2024

Tatva Chintan Pharma Chem Limited (TATVA) Stock Technical Analysis - Support, Resistance & Price A

Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and it's essential to conduct thorough research or consult with a financial advisor before making investment decisions. Tatva Chintan Pharma Chem Limited (TATVA) is experiencing weak price action around 839, trading well below its recent highs. The support levels are seen at 825 and 795, while resistance is expected at 861 and 893. The stock is in a consolidation phase with no strong directional momentum, as indicated by an ADX of 23. The RSI is at 43, signaling a neutral outlook, and the MACD is in a negative territory, suggesting bearish sentiment. However, the stock is trading at a substantial discount from its 52-week high, presenting potential upside if market conditions improve. Watch for a breakout above 861 or a breakdown below 825 for further price action.